ReP USP - Resultado da busca

Artigo de periodico
What can we learn from animal models to study schizophrenia? (2022)
Crunfli, Fernanda ; Del Bel, Elaine Aparecida ; Gomes, Felipe Villela ; Teles, Caroline Brandão; Zuccoli, Giuliana S.; Chaves Filho, Adriano J. M.; Vieira, Gabriela Maciel ; Amaral, Danyelle Silva; Crippa, José Alexandre de Souza ; Pedrazzi, João Francisco Cordeiro; Macêdo, Danielle S.
Fonte: Advances in Experimental Medicine and Biology. Unidades: FMRP, FORP
Assuntos: ESQUIZOFRENIA, MODELOS ANIMAIS, TRANSTORNOS PSICÓTICOS, NEUROTRANSMISSORES, GLUTAMATOS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUNFLI, Fernanda et al. What can we learn from animal models to study schizophrenia?. Advances in Experimental Medicine and Biology, v. 1400, p. 15-33, 2022Tradução . . Disponível em: https://doi.org/10.1007/978-3-030-97182-3_2. Acesso em: 09 set. 2024.
APA
Crunfli, F., Del Bel, E. A., Gomes, F. V., Teles, C. B., Zuccoli, G. S., Chaves Filho, A. J. M., et al. (2022). What can we learn from animal models to study schizophrenia? Advances in Experimental Medicine and Biology, 1400, 15-33. doi:10.1007/978-3-030-97182-3_2
NLM
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Vancouver
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Artigo de periodico
Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors (2022)
Souza, Adriana de Jesus; Cortez, Isadora L.; Silva, Nicole R.; Pedrazzi, João Francisco Cordeiro; Domingos, Luana B.; Braga, Matheus Silva; Silva, Thamyris Santos; Del Bel, Elaine Aparecida ; Resstel, Leonardo Barbosa Moraes ; Li, Guanguan; Mian, Md Yeunus; Sharmin, Dishary; Guimarães, Francisco Silveira ; Cook, James M.; Gomes, Felipe Villela
Fonte: Behavioural Brain Research. Unidades: FORP, FMRP
Assuntos: ANSIEDADE, DEPRESSÃO, ANTIPSICÓTICOS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Adriana de Jesus et al. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, v. 428, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2022.113832. Acesso em: 09 set. 2024.
APA
Souza, A. de J., Cortez, I. L., Silva, N. R., Pedrazzi, J. F. C., Domingos, L. B., Braga, M. S., et al. (2022). Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, 428, 1-11. doi:10.1016/j.bbr.2022.113832
NLM
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Vancouver
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Artigo de periodico
Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation (2022)
Santos-Lobato, Bruno L.; Gardinassi, Luiz Gustavo; Bortolanza, Mariza; Peti, Ana Paula Ferranti; Pimentel, Ângela V.; Faccioli, Lucia Helena ; Del Bel, Elaine Aparecida ; Tumas, Vitor
Fonte: Molecular Neurobiology. Unidades: FMRP, FCFRP, FORP
Assuntos: METABOLÔMICA, DOENÇA DE PARKINSON, DISCINESIAS, FÁRMACOS (SISTEMA NERVOSO CENTRAL)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS-LOBATO, Bruno L. et al. Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation. Molecular Neurobiology, v. 59, n. 2, p. 1140-1150, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12035-021-02625-1. Acesso em: 09 set. 2024.
APA
Santos-Lobato, B. L., Gardinassi, L. G., Bortolanza, M., Peti, A. P. F., Pimentel, Â. V., Faccioli, L. H., et al. (2022). Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation. Molecular Neurobiology, 59( 2), 1140-1150. doi:10.1007/s12035-021-02625-1
NLM
Santos-Lobato BL, Gardinassi LG, Bortolanza M, Peti APF, Pimentel ÂV, Faccioli LH, Del Bel EA, Tumas V. Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation [Internet]. Molecular Neurobiology. 2022 ; 59( 2): 1140-1150.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12035-021-02625-1
Vancouver
Santos-Lobato BL, Gardinassi LG, Bortolanza M, Peti APF, Pimentel ÂV, Faccioli LH, Del Bel EA, Tumas V. Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation [Internet]. Molecular Neurobiology. 2022 ; 59( 2): 1140-1150.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12035-021-02625-1
Artigo de periodico
Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels (2022)
Santos-Lobato, Bruno Lopes; Bortolanza, Mariza ; Pinheiro, Lucas Cezar ; Batalhão, Marcelo Eduardo; Pimentel, Angela Vieira; Cárnio, Evelin Capellari ; Del Bel, Elaine Aparecida ; Tumas, Vitor
Fonte: Journal of Neural Transmission. Unidades: FMRP, EERP, FORP
Assuntos: DOENÇA DE PARKINSON, METABOLISMO, ÓXIDO NÍTRICO, DISCINESIAS, LÍQUIDO CEFALORRAQUIDIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS-LOBATO, Bruno Lopes et al. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels. Journal of Neural Transmission, v. 129, n. 1, p. 55-63, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00702-021-02447-4. Acesso em: 09 set. 2024.
APA
Santos-Lobato, B. L., Bortolanza, M., Pinheiro, L. C., Batalhão, M. E., Pimentel, A. V., Cárnio, E. C., et al. (2022). Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels. Journal of Neural Transmission, 129( 1), 55-63. doi:10.1007/s00702-021-02447-4
NLM
Santos-Lobato BL, Bortolanza M, Pinheiro LC, Batalhão ME, Pimentel AV, Cárnio EC, Del Bel EA, Tumas V. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels [Internet]. Journal of Neural Transmission. 2022 ; 129( 1): 55-63.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s00702-021-02447-4
Vancouver
Santos-Lobato BL, Bortolanza M, Pinheiro LC, Batalhão ME, Pimentel AV, Cárnio EC, Del Bel EA, Tumas V. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels [Internet]. Journal of Neural Transmission. 2022 ; 129( 1): 55-63.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s00702-021-02447-4
Artigo de periodico
Cannabidiol for the treatment of autism spectrum disorder: hope or hype? (2022)
Pedrazzi, João Francisco Cordeiro; Ferreira, Frederico Rogério; Amaral, Danyelle Silva; Lima, Daniel Antunes; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Del Bel, Elaine Aparecida ; Guimarães, Francisco Silveira ; Costa, Karla Cristinne Mancini ; Campos, Alline Cristina de; Crippa, Ana C. S.; Crippa, José Alexandre de Souza
Fonte: Psychopharmacology. Unidades: FMRP, FORP
Assuntos: ANTIPSICÓTICOS, FARMACOTERAPIA, CANABINOIDES, CRIANÇAS EM IDADE PRÉ-ESCOLAR, TRANSTORNO DO DEFICIT DE ATENÇÃO COM HIPERATIVIDADE, TRANSTORNO DO ESPECTRO AUTISTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?. Psychopharmacology, v. 239, n. 9, p. 2713-2734, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-022-06196-4. Acesso em: 09 set. 2024.
APA
Pedrazzi, J. F. C., Ferreira, F. R., Amaral, D. S., Lima, D. A., Hallak, J. E. C., Zuardi, A. W., et al. (2022). Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology, 239( 9), 2713-2734. doi:10.1007/s00213-022-06196-4
NLM
Pedrazzi JFC, Ferreira FR, Amaral DS, Lima DA, Hallak JEC, Zuardi AW, Del Bel EA, Guimarães FS, Costa KCM, Campos AC de, Crippa ACS, Crippa JA de S. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? [Internet]. Psychopharmacology. 2022 ; 239( 9): 2713-2734.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s00213-022-06196-4
Vancouver
Pedrazzi JFC, Ferreira FR, Amaral DS, Lima DA, Hallak JEC, Zuardi AW, Del Bel EA, Guimarães FS, Costa KCM, Campos AC de, Crippa ACS, Crippa JA de S. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? [Internet]. Psychopharmacology. 2022 ; 239( 9): 2713-2734.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s00213-022-06196-4
Artigo de periodico
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia (2022)
Cortez, Isadora Lopes; Silva, Nicole R.; Rodrigues, Naielly S.; Pedrazzi, João Francisco Cordeiro; Del Bel, Elaine Aparecida ; Mechoulam, Raphael; Gomes, Felipe Villela ; Guimarães, Francisco Silveira
Fonte: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FORP, FMRP
Assuntos: CANABINOIDES, ESQUIZOFRENIA, FARMACOTERAPIA, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTEZ, Isadora Lopes et al. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 117, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2022.110553. Acesso em: 09 set. 2024.
APA
Cortez, I. L., Silva, N. R., Rodrigues, N. S., Pedrazzi, J. F. C., Del Bel, E. A., Mechoulam, R., et al. (2022). HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 1-9. doi:10.1016/j.pnpbp.2022.110553
NLM
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Vancouver
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Artigo de periodico
Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats (2021)
Estela, Airam Nicole Vivanco; Pereira, Maurício dos Santos; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida ; Nascimento, Glauce Crivelaro do
Fonte: Neuropharmacology. Unidades: FORP, FMRP
Assuntos: CANABINOIDES, ANALGÉSICOS, ANTICONVULSIVANTES, DOR FACIAL, NOCICEPTIVIDADE, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESTELA, Airam Nicole Vivanco et al. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology, v. 196, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108700. Acesso em: 09 set. 2024.
APA
Estela, A. N. V., Pereira, M. dos S., Guimarães, F. S., Del Bel, E. A., & Nascimento, G. C. do. (2021). Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology, 196. doi:10.1016/j.neuropharm.2021.108700
NLM
Estela ANV, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108700
Vancouver
Estela ANV, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108700
Artigo de periodico
Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment (2021)
Ferreira, Frederico Rogério; Cupido, Alexander; Catalin, Bogdan; Silva Junior, Wilson Araújo da ; Kirchhoff, Frank; Del Bel, Elaine Aparecida ; Guimarães, Francisco Silveira
Fonte: Neurotoxicity Research. Unidades: FMRP, FORP
Assuntos: ASTRÓCITOS, CALMODULINA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Frederico Rogério et al. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment. Neurotoxicity Research, v. 39, n. 3, p. 860-871, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12640-021-00334-0. Acesso em: 09 set. 2024.
APA
Ferreira, F. R., Cupido, A., Catalin, B., Silva Junior, W. A. da, Kirchhoff, F., Del Bel, E. A., & Guimarães, F. S. (2021). Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment. Neurotoxicity Research, 39( 3), 860-871. doi:10.1007/s12640-021-00334-0
NLM
Ferreira FR, Cupido A, Catalin B, Silva Junior WA da, Kirchhoff F, Del Bel EA, Guimarães FS. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment [Internet]. Neurotoxicity Research. 2021 ; 39( 3): 860-871.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12640-021-00334-0
Vancouver
Ferreira FR, Cupido A, Catalin B, Silva Junior WA da, Kirchhoff F, Del Bel EA, Guimarães FS. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment [Internet]. Neurotoxicity Research. 2021 ; 39( 3): 860-871.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12640-021-00334-0
Artigo de periodico
Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum (2021)
Pedrazzi, João Francisco Cordeiro; Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Joca, Sâmia Regiane Lourenço ; Crippa, José Alexandre de Souza ; Del Bel, Elaine Aparecida
Fonte: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FMRP, FCFRP, FORP
Assuntos: ANFETAMINAS, ANTIPSICÓTICOS, COMPORTAMENTO ANIMAL, CANABINOIDES, METILAÇÃO DE DNA, CÓRTEX PRÉ-FRONTAL, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 111, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2021.110352. Acesso em: 09 set. 2024.
APA
Pedrazzi, J. F. C., Sales, A. J., Guimarães, F. S., Joca, S. R. L., Crippa, J. A. de S., & Del Bel, E. A. (2021). Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111. doi:10.1016/j.pnpbp.2021.110352
NLM
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Vancouver
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Artigo de periodico
The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress (2021)
Ferreira Junior, Nilson Carlos; Pereira, Maurício dos Santos ; Francis, Nour; Ramirez, Paola; Martorell, Paula; González-Lizarraga, Florencia; Figadère, Bruno; Chehin, Rosana; Del Bel, Elaine Aparecida ; Raisman-Vozari, Rita; Michel, Patrick Pierre
Fonte: Cells. Unidade: FORP
Assuntos: ESTRESSE OXIDATIVO, GLICOSE, METABOLISMO, ANTIBIÓTICOS, AGENTES ANTIMICROBIANOS, FARMACOLOGIA EXPERIMENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA JUNIOR, Nilson Carlos et al. The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress. Cells, v. 10, n. 8, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3390/cells10082163. Acesso em: 09 set. 2024.
APA
Ferreira Junior, N. C., Pereira, M. dos S., Francis, N., Ramirez, P., Martorell, P., González-Lizarraga, F., et al. (2021). The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress. Cells, 10( 8), 1-16. doi:10.3390/cells10082163
NLM
Ferreira Junior NC, Pereira M dos S, Francis N, Ramirez P, Martorell P, González-Lizarraga F, Figadère B, Chehin R, Del Bel EA, Raisman-Vozari R, Michel PP. The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress [Internet]. Cells. 2021 ; 10( 8): 1-16.[citado 2024 set. 09 ] Available from: https://doi.org/10.3390/cells10082163
Vancouver
Ferreira Junior NC, Pereira M dos S, Francis N, Ramirez P, Martorell P, González-Lizarraga F, Figadère B, Chehin R, Del Bel EA, Raisman-Vozari R, Michel PP. The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress [Internet]. Cells. 2021 ; 10( 8): 1-16.[citado 2024 set. 09 ] Available from: https://doi.org/10.3390/cells10082163
Artigo de periodico
The antibiotic doxycycline mimics the NGF signaling in PC12 cells:: a relevant mechanism for neuroprotection (2021)
Amaral, Lilian do ; Santos, Neife Aparecida Guinaim dos; Sisti, Flávia Malvestio; Del Bel, Elaine Aparecida ; Santos, Antônio Cardozo dos
Fonte: Chemico-Biological Interactions. Unidades: FCFRP, FORP
Assuntos: ANTIBIÓTICOS, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Lilian do et al. The antibiotic doxycycline mimics the NGF signaling in PC12 cells:: a relevant mechanism for neuroprotection. Chemico-Biological Interactions, v. 341, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2021.109454. Acesso em: 09 set. 2024.
APA
Amaral, L. do, Santos, N. A. G. dos, Sisti, F. M., Del Bel, E. A., & Santos, A. C. dos. (2021). The antibiotic doxycycline mimics the NGF signaling in PC12 cells:: a relevant mechanism for neuroprotection. Chemico-Biological Interactions, 341, 1-12. doi:10.1016/j.cbi.2021.109454
NLM
Amaral L do, Santos NAG dos, Sisti FM, Del Bel EA, Santos AC dos. The antibiotic doxycycline mimics the NGF signaling in PC12 cells:: a relevant mechanism for neuroprotection [Internet]. Chemico-Biological Interactions. 2021 ; 341 1-12.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.cbi.2021.109454
Vancouver
Amaral L do, Santos NAG dos, Sisti FM, Del Bel EA, Santos AC dos. The antibiotic doxycycline mimics the NGF signaling in PC12 cells:: a relevant mechanism for neuroprotection [Internet]. Chemico-Biological Interactions. 2021 ; 341 1-12.[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.cbi.2021.109454
Artigo de periodico
In-tube solid-phase microextraction directly coupled to tandem mass spectrometry for anandamide and 2-arachidonoylglycerol determination in rat brain samples from an animal model of Parkinson's disease (2021)
Oliveira, Igor Gustavo de Carvalho; Souza, Israel Donizéti de ; Nascimento, Glauce Crivelaro do ; Del Bel, Elaine Aparecida ; Queiroz, Maria Eugênia Costa
Fonte: Journal of Chromatography A. Unidades: FFCLRP, FORP
Assuntos: ÁCIDOS ARAQUIDÔNICOS, CÉREBRO, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, GLICERÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Igor Gustavo de Carvalho et al. In-tube solid-phase microextraction directly coupled to tandem mass spectrometry for anandamide and 2-arachidonoylglycerol determination in rat brain samples from an animal model of Parkinson's disease. Journal of Chromatography A, v. 1636, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.chroma.2020.461766. Acesso em: 09 set. 2024.
APA
Oliveira, I. G. de C., Souza, I. D. de, Nascimento, G. C. do, Del Bel, E. A., & Queiroz, M. E. C. (2021). In-tube solid-phase microextraction directly coupled to tandem mass spectrometry for anandamide and 2-arachidonoylglycerol determination in rat brain samples from an animal model of Parkinson's disease. Journal of Chromatography A, 1636. doi:10.1016/j.chroma.2020.461766
NLM
Oliveira IG de C, Souza ID de, Nascimento GC do, Del Bel EA, Queiroz MEC. In-tube solid-phase microextraction directly coupled to tandem mass spectrometry for anandamide and 2-arachidonoylglycerol determination in rat brain samples from an animal model of Parkinson's disease [Internet]. Journal of Chromatography A. 2021 ; 1636[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.chroma.2020.461766
Vancouver
Oliveira IG de C, Souza ID de, Nascimento GC do, Del Bel EA, Queiroz MEC. In-tube solid-phase microextraction directly coupled to tandem mass spectrometry for anandamide and 2-arachidonoylglycerol determination in rat brain samples from an animal model of Parkinson's disease [Internet]. Journal of Chromatography A. 2021 ; 1636[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.chroma.2020.461766
Artigo de periodico
Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease (2021)
Pereira, Maurício dos Santos ; Abreu, Gabriel Henrique Dias; Rocca, Jeremy; Hamadat, Sabah; Raisman-Vozari, Rita; Michel, Patrick Pierre; Del Bel, Elaine Aparecida
Fonte: Frontiers in Pharmacology. Unidade: FORP
Assuntos: ASTROCITOMA, CANABINOIDES, GLUTAMATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Maurício dos Santos et al. Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease. Frontiers in Pharmacology, v. 11, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.617085. Acesso em: 09 set. 2024.
APA
Pereira, M. dos S., Abreu, G. H. D., Rocca, J., Hamadat, S., Raisman-Vozari, R., Michel, P. P., & Del Bel, E. A. (2021). Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease. Frontiers in Pharmacology, 11, 1-16. doi:10.3389/fphar.2020.617085
NLM
Pereira M dos S, Abreu GHD, Rocca J, Hamadat S, Raisman-Vozari R, Michel PP, Del Bel EA. Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease [Internet]. Frontiers in Pharmacology. 2021 ; 11 1-16.[citado 2024 set. 09 ] Available from: https://doi.org/10.3389/fphar.2020.617085
Vancouver
Pereira M dos S, Abreu GHD, Rocca J, Hamadat S, Raisman-Vozari R, Michel PP, Del Bel EA. Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease [Internet]. Frontiers in Pharmacology. 2021 ; 11 1-16.[citado 2024 set. 09 ] Available from: https://doi.org/10.3389/fphar.2020.617085
Artigo de periodico
Beneficial effects of benzodiazepine on masticatory muscle dysfunction induced by chronic stress and occlusal instability in an experimental animal study (2020)
Nascimento, Glauce Crivelaro do ; Malzone, Bruno Lima; Iyomasa, Daniela Mizusaki ; Pereira, Yamba Carla Lara; Issa, João Paulo Mardegan ; Panissi, Christie Ramos Andrade Leite ; Watanabe, Ii-sei ; Iyomasa, Mamie Mizusaki ; Fuentes, Ramón ; Del Bel, Elaine Aparecida ; Dias, Fernando Jose
Fonte: Scientific Reports. Unidades: FORP, FFCLRP, ICB
Assuntos: ANATOMIA, RATOS WISTAR, MANDÍBULA, MÚSCULOS MASTIGATÓRIOS, DISFUNÇÃO TEMPOROMANDIBULAR, DOENÇA DA ARTICULAÇÃO TEMPOROMANDIBULAR, ESTRESSE PSICOLÓGICO, ALTERAÇÕES DENTÁRIAS REGRESSIVAS, MÚSCULO PTERIGOIDE MEDIAL, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Glauce Crivelaro do et al. Beneficial effects of benzodiazepine on masticatory muscle dysfunction induced by chronic stress and occlusal instability in an experimental animal study. Scientific Reports, v. 10, p. 10, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-65524-w. Acesso em: 09 set. 2024.
APA
Nascimento, G. C. do, Malzone, B. L., Iyomasa, D. M., Pereira, Y. C. L., Issa, J. P. M., Panissi, C. R. A. L., et al. (2020). Beneficial effects of benzodiazepine on masticatory muscle dysfunction induced by chronic stress and occlusal instability in an experimental animal study. Scientific Reports, 10, 10. doi:10.1038/s41598-020-65524-w
NLM
Nascimento GC do, Malzone BL, Iyomasa DM, Pereira YCL, Issa JPM, Panissi CRAL, Watanabe I-sei, Iyomasa MM, Fuentes R, Del Bel EA, Dias FJ. Beneficial effects of benzodiazepine on masticatory muscle dysfunction induced by chronic stress and occlusal instability in an experimental animal study [Internet]. Scientific Reports. 2020 ; 10 10.[citado 2024 set. 09 ] Available from: https://doi.org/10.1038/s41598-020-65524-w
Vancouver
Nascimento GC do, Malzone BL, Iyomasa DM, Pereira YCL, Issa JPM, Panissi CRAL, Watanabe I-sei, Iyomasa MM, Fuentes R, Del Bel EA, Dias FJ. Beneficial effects of benzodiazepine on masticatory muscle dysfunction induced by chronic stress and occlusal instability in an experimental animal study [Internet]. Scientific Reports. 2020 ; 10 10.[citado 2024 set. 09 ] Available from: https://doi.org/10.1038/s41598-020-65524-w
Artigo de periodico
Effects of doxycycline in swiss mice predictive models of schizophrenia (2020)
Pereira, Ana Carolina de Castro Issy; Pedrazzi, João Francisco Cordeiro; Oosten, Anna Beatriz Saito van; Checheto, Thiago; Silva, Rafaela R.; Noël, François; Del Bel, Elaine Aparecida
Fonte: Neurotoxicity Research. Unidades: FCFRP, FORP, FMRP
Assuntos: ESQUIZOFRENIA, MODELOS ANIMAIS, FARMACOLOGIA, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Ana Carolina de Castro Issy et al. Effects of doxycycline in swiss mice predictive models of schizophrenia. Neurotoxicity Research, v. 38, n. 4, p. 1049-1060, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12640-020-00268-z. Acesso em: 09 set. 2024.
APA
Pereira, A. C. de C. I., Pedrazzi, J. F. C., Oosten, A. B. S. van, Checheto, T., Silva, R. R., Noël, F., & Del Bel, E. A. (2020). Effects of doxycycline in swiss mice predictive models of schizophrenia. Neurotoxicity Research, 38( 4), 1049-1060. doi:10.1007/s12640-020-00268-z
NLM
Pereira AC de CI, Pedrazzi JFC, Oosten ABS van, Checheto T, Silva RR, Noël F, Del Bel EA. Effects of doxycycline in swiss mice predictive models of schizophrenia [Internet]. Neurotoxicity Research. 2020 ; 38( 4): 1049-1060.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12640-020-00268-z
Vancouver
Pereira AC de CI, Pedrazzi JFC, Oosten ABS van, Checheto T, Silva RR, Noël F, Del Bel EA. Effects of doxycycline in swiss mice predictive models of schizophrenia [Internet]. Neurotoxicity Research. 2020 ; 38( 4): 1049-1060.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12640-020-00268-z
Artigo de periodico
One-week high-intensity interval training increases hippocampal plasticity and mitochondrial content without changes in redox state (2020)
Santos, Jonathas Rodrigo dos; Bortolanza, Mariza; Ferrari, Gustavo Duarte ; Lanfredi, Guilherme Pauperio ; Nascimento, Glauce Crivelaro do ; Azzolini, Ana Elisa Caleiro Seixas ; Del Bel, Elaine Aparecida ; Campos, Alline Cristina de; Faça, Vitor Marcel ; Vulczak, Anderson; Alberici, Luciane Carla
Fonte: Antioxidants. Unidades: FMRP, FORP, FCFRP
Assuntos: EXERCÍCIO FÍSICO, ESTRESSE OXIDATIVO, NEUROGENÉTICA, CÉREBRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Jonathas Rodrigo dos et al. One-week high-intensity interval training increases hippocampal plasticity and mitochondrial content without changes in redox state. Antioxidants, v. 9, n. 5, 2020Tradução . . Disponível em: https://doi.org/10.3390/antiox9050445. Acesso em: 09 set. 2024.
APA
Santos, J. R. dos, Bortolanza, M., Ferrari, G. D., Lanfredi, G. P., Nascimento, G. C. do, Azzolini, A. E. C. S., et al. (2020). One-week high-intensity interval training increases hippocampal plasticity and mitochondrial content without changes in redox state. Antioxidants, 9( 5). doi:10.3390/antiox9050445
NLM
Santos JR dos, Bortolanza M, Ferrari GD, Lanfredi GP, Nascimento GC do, Azzolini AECS, Del Bel EA, Campos AC de, Faça VM, Vulczak A, Alberici LC. One-week high-intensity interval training increases hippocampal plasticity and mitochondrial content without changes in redox state [Internet]. Antioxidants. 2020 ; 9( 5):[citado 2024 set. 09 ] Available from: https://doi.org/10.3390/antiox9050445
Vancouver
Santos JR dos, Bortolanza M, Ferrari GD, Lanfredi GP, Nascimento GC do, Azzolini AECS, Del Bel EA, Campos AC de, Faça VM, Vulczak A, Alberici LC. One-week high-intensity interval training increases hippocampal plasticity and mitochondrial content without changes in redox state [Internet]. Antioxidants. 2020 ; 9( 5):[citado 2024 set. 09 ] Available from: https://doi.org/10.3390/antiox9050445
Artigo de periodico
Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption (2020)
Pereira, Maurício dos Santos; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida ; Raisman-Vozari, Rita; Michel, Patrick P.
Fonte: Glia. Unidades: FMRP, FORP
Assuntos: CANABINOIDES, GLICOSE, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Maurício dos Santos et al. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption. Glia, v. 68, n. 3, p. 561-573, 2020Tradução . . Disponível em: https://doi.org/10.1002/glia.23738. Acesso em: 09 set. 2024.
APA
Pereira, M. dos S., Guimarães, F. S., Del Bel, E. A., Raisman-Vozari, R., & Michel, P. P. (2020). Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption. Glia, 68( 3), 561-573. doi:10.1002/glia.23738
NLM
Pereira M dos S, Guimarães FS, Del Bel EA, Raisman-Vozari R, Michel PP. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption [Internet]. Glia. 2020 ; 68( 3): 561-573.[citado 2024 set. 09 ] Available from: https://doi.org/10.1002/glia.23738
Vancouver
Pereira M dos S, Guimarães FS, Del Bel EA, Raisman-Vozari R, Michel PP. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption [Internet]. Glia. 2020 ; 68( 3): 561-573.[citado 2024 set. 09 ] Available from: https://doi.org/10.1002/glia.23738
Artigo de periodico
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease (2020)
Nascimento, Glauce Crivelaro do; Ferrari, Daniele Pereira; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida ; Bortolanza, Mariza; Ferreira Junior, Nilson Carlos
Fonte: Neuropharmacology. Unidades: FORP, FMRP
Assuntos: CANABINOIDES, NOCICEPTIVIDADE, DOR, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Glauce Crivelaro do et al. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease. Neuropharmacology, v. 163, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2019.107808. Acesso em: 09 set. 2024.
APA
Nascimento, G. C. do, Ferrari, D. P., Guimarães, F. S., Del Bel, E. A., Bortolanza, M., & Ferreira Junior, N. C. (2020). Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease. Neuropharmacology, 163. doi:10.1016/j.neuropharm.2019.107808
NLM
Nascimento GC do, Ferrari DP, Guimarães FS, Del Bel EA, Bortolanza M, Ferreira Junior NC. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease [Internet]. Neuropharmacology. 2020 ; 163[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.107808
Vancouver
Nascimento GC do, Ferrari DP, Guimarães FS, Del Bel EA, Bortolanza M, Ferreira Junior NC. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease [Internet]. Neuropharmacology. 2020 ; 163[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.107808
Artigo de periodico
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects (2020)
González-Lizárraga, Florencia; Ploper, Diego; Ávila, César L.; Socías, Sergio B.; Pereira, Mauricio dos Santos; Machín, Belén; Del Bel, Elaine Aparecida ; Michel, Patrick Pierre; Pietrasanta, Lía I.; Raisman-Vozari, Rita; Chehín, Rosana
Fonte: Scientific Reports. Unidade: FORP
Assuntos: REPOSICIONAMENTO DE FÁRMACOS, INFLAMAÇÃO, DOENÇA DE PARKINSON, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONZÁLEZ-LIZÁRRAGA, Florencia et al. CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects. Scientific Reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-76927-0. Acesso em: 09 set. 2024.
APA
González-Lizárraga, F., Ploper, D., Ávila, C. L., Socías, S. B., Pereira, M. dos S., Machín, B., et al. (2020). CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects. Scientific Reports, 10( 1). doi:10.1038/s41598-020-76927-0
NLM
González-Lizárraga F, Ploper D, Ávila CL, Socías SB, Pereira M dos S, Machín B, Del Bel EA, Michel PP, Pietrasanta LI, Raisman-Vozari R, Chehín R. CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 set. 09 ] Available from: https://doi.org/10.1038/s41598-020-76927-0
Vancouver
González-Lizárraga F, Ploper D, Ávila CL, Socías SB, Pereira M dos S, Machín B, Del Bel EA, Michel PP, Pietrasanta LI, Raisman-Vozari R, Chehín R. CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 set. 09 ] Available from: https://doi.org/10.1038/s41598-020-76927-0
Artigo de periodico
Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia (2020)
Ferreira Junior, Nilson Carlos ; Pereira, Maurício dos Santos; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Fonte: Neurotoxicity Research. Unidades: FMRP, FORP
Assuntos: RECEPTORES, CANABINOIDES, INFLAMAÇÃO, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA JUNIOR, Nilson Carlos et al. Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia. Neurotoxicity Research, v. 37, n. 1, p. 12-29, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12640-019-00109-8. Acesso em: 09 set. 2024.
APA
Ferreira Junior, N. C., Pereira, M. dos S., Guimarães, F. S., & Del Bel, E. A. (2020). Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia. Neurotoxicity Research, 37( 1), 12-29. doi:10.1007/s12640-019-00109-8
NLM
Ferreira Junior NC, Pereira M dos S, Guimarães FS, Del Bel EA. Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia [Internet]. Neurotoxicity Research. 2020 ; 37( 1): 12-29.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12640-019-00109-8
Vancouver
Ferreira Junior NC, Pereira M dos S, Guimarães FS, Del Bel EA. Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia [Internet]. Neurotoxicity Research. 2020 ; 37( 1): 12-29.[citado 2024 set. 09 ] Available from: https://doi.org/10.1007/s12640-019-00109-8

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos